Precise Biometrics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	82.58	86.85	75.07	91.02	83.32	92.35
Revenue Growth (YoY)	-3.27%	15.70%	-17.52%	9.24%	-9.78%	0.46%
Cost of Revenue	21.97	23.79	27.25	25.98	19.78	14.58
Gross Profit	60.61	63.07	47.82	65.04	63.54	77.77
Selling, General & Admin	47.57	46.77	41.57	52.41	47.09	45.92
Research & Development	27.03	26.97	32.11	34.91	28.16	35.94
Other Operating Expenses	1.49	-1.26	0.61	-2.26	-0.21	1.7
Operating Expenses	76.09	72.48	74.28	85.05	75.04	83.56
Operating Income	-15.48	-9.42	-26.46	-20.02	-11.5	-5.79
Interest Expense	-0.81	-0.39	-1	-3.41	-0.22	-0.1
Interest & Investment Income	0.89	0.89	0.54	-	-	0.01
Currency Exchange Gain (Loss)	0.12	0.12	0.17	-0.04	0.95	-0.58
Other Non Operating Income (Expenses)	0	0	-	-	-	0.05
EBT Excluding Unusual Items	-15.26	-8.78	-26.75	-23.47	-10.77	-6.41
Merger & Restructuring Charges	-	-	-	-	-2.58	-
Pretax Income	-15.26	-8.78	-26.75	-23.47	-13.35	-6.41
Income Tax Expense	-0.35	-0.35	-0.35	-1.24	0.1	5.75
Earnings From Continuing Operations	-14.91	-8.43	-26.4	-22.23	-13.45	-12.16
Earnings From Discontinued Operations	-	-	-	-	-	-0.08
Net Income	-14.91	-8.43	-26.4	-22.23	-13.45	-12.24
Net Income to Common	-14.91	-8.43	-26.4	-22.23	-13.45	-12.24
Shares Outstanding (Basic)	78	78	66	41	36	36
Shares Outstanding (Diluted)	78	78	66	41	36	36
Shares Change (YoY)	19.67%	19.67%	58.75%	14.02%	0.56%	-0.18%
EPS (Basic)	-0.19	-0.11	-0.40	-0.54	-0.37	-0.34
EPS (Diluted)	-0.19	-0.11	-0.40	-0.54	-0.37	-0.34
Free Cash Flow	9.6	9.69	-11.98	3.65	-4.32	19.73
Free Cash Flow Per Share	0.12	0.12	-0.18	0.09	-0.12	0.55
Gross Margin	73.39%	72.61%	63.70%	71.45%	76.27%	84.21%
Operating Margin	-18.74%	-10.84%	-35.24%	-21.99%	-13.80%	-6.27%
Profit Margin	-18.06%	-9.71%	-35.17%	-24.42%	-16.14%	-13.25%
Free Cash Flow Margin	11.63%	11.15%	-15.95%	4.01%	-5.18%	21.37%
EBITDA	-12.05	-5.72	-22.53	-15.83	-9.31	-4.37
EBITDA Margin	-14.59%	-6.58%	-30.02%	-17.39%	-11.17%	-4.73%
D&A For EBITDA	3.43	3.7	3.92	4.18	2.19	1.42
EBIT	-15.48	-9.42	-26.46	-20.02	-11.5	-5.79
EBIT Margin	-18.74%	-10.84%	-35.24%	-21.99%	-13.80%	-6.27%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.